What is the Current Share Price of Kimia Biosciences Ltd?
- Answer Field
-
Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 33.50 as on Feb 19 2026 03:29 PM.
As of the latest trading session, KIMIA BIOSCIENCES LIMITED share price is currently at ₹33.5, which is down by ₹-2.16 from its previous closing. Today, the stock has fluctuated between ₹33.00 and ₹37.00. Over the past year, KIMIA BIOSCIENCES LIMITED has achieved a return of -23.41%. In the last month alone, the return has been 15.62%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 30.10 |
| Operating Expense | 25.15 |
| Net Profit | 5.44 |
| Net Profit Margin (%) | 18.07 |
| Earnings Per Share (EPS) | 1.15 |
| EBITDA | 6.64 |
| Effective Tax Rate (%) | -7.72 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 27.49 | 11.90 | 1.42 | 210.66 | 23.12 / 46.00 |
| BLISS GVS PHARMA LTD | 229.90 | 21.98 | 2.14 | 2432.09 | 105.05 / 244.05 |
| CIPLA LTD | 1349.10 | 22.92 | 3.31 | 108977.69 | 1283.00 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 327.30 | 10.89 | 2.46 | 963.28 | 219.00 / 399.00 |
| GLAXOSMITHKLINE PHARMA LT | 2584.40 | 43.53 | 25.63 | 43781.30 | 2220.00 / 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 27.49 | 26.43 | 3.83 | 210.66 | 23.12 / 46.00 |
| AMRUTAJAN HEALTH LTD | 628.00 | 31.40 | 5.30 | 1815.59 | 548.05 / 789.95 |
| ASTRAZENECA PHARMA IND LT | 8888.85 | 106.82 | 27.81 | 22222.13 | 6501.60 / 10653.05 |
| BLISS GVS PHARMA LTD | 229.90 | 31.32 | 2.20 | 2432.09 | 105.05 / 244.05 |
Choose a Plan That Suits Your Goals and Needs
Subscription Charge : FREE
Professional Pack
Subscription Charge : ₹2,500 Yearly
Signature
Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019. Since then, it engages in the business of Pharmaceutical products.
The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95.
During the 1998-99, the company has become a sick industrial units.
The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.
Pursuant to Scheme of Amalgamation as approved by NCLT vide its order dated August 21, 2018, the business of Kimia Biosciences Limited, which was engaged in the business of Sale & Manufacturing of Bulk Drugs (API)), was merged with the business of the Company as going concern, making the Scheme effective from September 17, 2018. The merger involved the consolidation of 37,28,100 equity shares held by Kimia Biosciences Limited.
Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 33.50 as on Feb 19 2026 03:29 PM.
The market cap of Kimia Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 158.50 as on Feb 19 2026 03:29 PM.
The 52 Week High and Low of Kimia Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 86.85 and ₹ 26.09.
The 1 year returns on the stock has been -23.41%.
As on Feb 19 2026 03:29 PM the price-to-earnings (PE) ratio for Kimia Biosciences Ltd share is 20.61.
As on Feb 19 2026 03:29 PM, the price-to-book (PB) ratio for Kimia Biosciences Ltd share is 2.44.
You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a demat account.
To buy Kimia Biosciences Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Kimia Biosciences Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
Freedom Pack